Endoscopic operations in invasive cancer of the urinary bladder


Дәйексөз келтіру

Толық мәтін

Аннотация

Long-term results of conservative treatment of 153 patients with invasive cancer of the urinary bladder were studied retrospectively. The patients had stage T2 (n = 121, 79.1%), T3 (n = 26, 17%), T4 (n = 6, 3.9%). All the patients had transitional cell cancer. Gl, G2 and G3 tumors were registered in 104(68%), 35(24%) and 12(8%) cases, respectively. 88 (57.5%) patients received combined treatment, 65(42.5%) patients - only surgery. In the patients with a small invasive tumor of the urinary bladder subjected to surgery alone (TUR-vaporization), overall 5-year survival was 70.4%. In patients with advanced cancer of the urinary bladder who had received curative radiotherapy in case of superficial residual tumor had TUR-vaporization of the urinary bladder overall 5-year survival was 76.5%. In patients exposed to large-fraction (TFD 20-25 Gy) preoperative radiotherapy followed by TUR-vaporization, survival at this moment was 84.6%. Three-year overall and recurrence-free survival at stage T2 was 97.5 and 47.4%, respectively; at stage T3 and T4 overall 3-year survival was 57.1 and 26.6%, respectively. Thus, the conclusion is that transurethral electrosurgery in conservative therapy of patients with invasive cancer of the urinary bladder is a promising approach.

Әдебиет тізімі

  1. Яненко Э. К., Кульга Л. Г., Поповкин Н. Н. и др. Распространенность рака мочевого пузыря в России и разработка методов его профилактики и лечения. В кн.: Рак мочевого пузыря: Материалы Всероссийской науч. конф. Ростов-н/ Д.; 1998. 106-107.
  2. Чиссов В. И., Старинский. Состояние онкологической помощи населению России в 2000 г. В кн.: Сборник МНИОИ им. Герцена П. А. М.; 2001. 191.
  3. Матвеев Б. П., Фигурин К. М., Корякин О. Б. Рак мочевого пузыря. М.: Вердана; 2001.
  4. Переверзев А. С. Можно ли оспаривать возможность органосохраняющих операций при раке мочевого пузыря. В кн.: Актуальные вопросы лечения онкоурологических заболеваний: Материалы 4-й Всероссийской конф. с участием стран СНГ. М.; 2001. 73-74.
  5. Попов А. М., Корякин О. Б. Органосохраняющее лечение инвазивного рака мочевого пузыря.
  6. Thunnan S. A., DeWeese T. L. Multimodality therapy for the treatment of muscle-invasive bladder cancer. Semin. Urol. Oncol. 2000; 18 (4): 313-322.
  7. Zietman A. L., Shipley W. U., Kaufman D. S. Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy. Ann. Med. 2000; 32 (1): 34-42.
  8. Juffs H. G., Moore M. J., Tannock I. F. The role of systemic chemotherapy in the management of muscle-invasive bladder cancer. Lancet Oncol. 2002. 3(12): 738-742.
  9. Kim H. L., Steinberg G. D. The current status of bladder preservation in the treatment of muscle invasive bladder cancer. J. Urol. (Baltimore) 2000; 164 (3, pt 1): 627-632.
  10. Лопаткин Н. А. Оперативное лечение опухолей мочевого пузыря. В кн.: Материалы пленума Всероссийского о-ва урологов. Кемерово; 1995. 157-174.
  11. Sweeney P., Kursh E. D., Resnick M. I. Partial cystectomy. Urol. Clin. North Am. 1992; 19: 10701-10711.
  12. Barnes R. W., Dick A. L., Handley H. L. et al. Survival following transurethral resection bladder carcinoma. Cancer Res. 1977; 37: 2895-2898.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2005